The role of positron emission tomography (PET) in the management of lymphoma patients

This publication has 15 references indexed in Scilit:

• Whole-body 2-[18F]-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) for accurate staging of Hodgkin’s disease
  Annals of Oncology, 1998
• Whole-body positron emission tomography using fluorodeoxyglucose for staging of lymphoma: effectiveness and comparison with computed tomography
  European Journal of Nuclear Medicine and Molecular Imaging, 1998
• Extranodal malignant lymphoma: detection with FDG PET versus CT.
  Radiology, 1998
• High-Dose Chemotherapy and Autologous Bone Marrow Transplantation Compared with MACOP-B in Aggressive B-Cell Lymphoma
  New England Journal of Medicine, 1997
• 67Ga scintigraphy for the evaluation of recurrences and residual masses in patients with lymphoma
  Nuclear Medicine Communications, 1997
• Gallium scans in the management of patients with Hodgkin's disease: a study of 101 patients.
  Journal of Clinical Oncology, 1997
• Magnetic resonance imaging and67ga scan versus computed tomography in the staging and in the monitoring of mediastinal malignant lymphoma: a prospective pilot study
  Magnetic Resonance Materials in Physics, Biology and Medicine, 1996
• Monitoring Bulky Mediastinal Disease with Gallium-67, CT-Scan and Magnetic Resonance Imaging in Hodgkin's Disease and High-Grade Non-Hodgkin's Lymphoma
  Leukemia & Lymphoma, 1996
• A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments]
  Blood, 1994
• PET and [11C]methionine in assessment of response in non-Hodgkin lymphoma
  The Lancet, 1990